Atlas Trials

Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress

Clinical trial NCT02184507 · COMPLETED

Trial details

NCT number
NCT02184507
Sponsor
Mohammad Hassan Eftekhari
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2013-06-01
Primary completion
2014-03-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.